General Characteristics of Adjuvants and Their Mechanism of Action (Part 1)

by N. A. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya, L. A. Gayderova
Published 2020-12-01

Immune Response Induced by Immunisation with Antiviral Vaccines

by N. A. Alpatova, Zh. I. Avdeeva, L. A. Gayderova, S. L. Lysikova, N. V. Medunitsyn
Published 2020-03-01

Orphan drugs and the principles of their marketing authorization procedures and clinical use

by A. A. Soldatov, Zh. I. Avdeeva, N. A. Alpatova, N. V. Medunitsyn, S. L. Lysikova
Published 2018-02-01

Recommendations for Expounding Evaluation of Biological (Specific) Activity of Biotechnological Products in Product Specification Files

by O. V. Golovinskaya, S. L. Lysikova, Yu. N. Lebedeva, N. A. Alpatova, A. A. Movsesyants, V. A. Merkulov
Published 2018-09-01

Pharmacokinetic properties of the preparations of protein origin

by A. A. Soldatov, Zh. I. Avdeeva, N. A. Alpatova, N. V. Medunitsyn, S. L. Lysikova, V. A. Merkulov
Published 2018-02-01

Comparative Analysis of Dyes Used in the Assessment of Filgrastim Products Specific Activity by Biological <i>in vitro</i> Methods

by O. V. Golovinskaya, M. L. Baykova, N. A. Alpatova, D. A. Zubkov, V. V. Fomenko, L. A. Gayderova
Published 2020-09-01

The possibility of harmonizing the recombinant erythropoietin specific activity determination method with European Pharmacopoeia

by A. K. Yakovlev, L. A. Gayderova, V. N. Podkuiko, R. A. Volkova, N. A. Alpatova, Yu. V. Olefir
Published 2017-05-01

Assessment of biotechnological products specific activity

by N. A. Alpatova, L. A. Gayderova, A. K. Yakovlev, E. V. Motuzova, S. L. Lysikova, A. A. Soldatov, Zh. I. Avdeeva
Published 2018-02-01

The stages in standardizing erythropoietin preparations

by A. K. Yakovlev, L. A. Gayderova, N. A. Alpatova, T. N. Lobanova, T. A. Batuashvili, L. V. Simutenko, E. L. Postnova, E. I. Yurchikova
Published 2018-02-01

Preparations of next generation monoclonal antibodies (issues and prospects)

by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, N. V. Medunitsyn, V. P. Bondarev, A. N. Mironov, V. A. Merkulov, I. V. Sakaeva
Published 2018-02-01

First available biosimilar monoclonal antibodies

by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, V. P. Bondarev, Yu. V. Olefir, V. A. Merkulov, V. D. Mosyagin, N. V. Medunitsyn
Published 2018-02-01

Studying of the standardization principles of pharmacological activity of recombinant erythropoietin preparations

by A. K. Yakovlev, L. A. Gayderova, N. A. Alpatova, T. N. Lobanova, E. L. Postnova, E. I. Yurchikova, T. A. Batuashvili, R. A. Volkova, V. N. Podkuiko, Yu. V. Olefir
Published 2017-05-01

Recombinant granulocyte colony stimulating factor biosimilars. Quality assessment

by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, M. V. Kiselevsky, S. L. Lysikova, V. P. Bondarev, N. V. Medunitsyn, V. D. Mosyagin, V. A. Merkulov, A. N. Mironov
Published 2018-02-01

Development and certification of an industrial reference standard for determination of filgrastim activity

by E. V. Motuzova, N. A. Alpatova, L. A. Gayderova, O. B. Runova, R. A. Volkova, E. D. Mytsa, V. P. Bondarev, A. A. Wainson, V. V. Mesherikova, R. A. Khamitov
Published 2018-02-01

Vaccines with adjuvants. Preclinical studies

by Zh. I. Avdeeva, N. A. Alpatova, V. P. Bondarev, R. A. Volkova, N. I. Lonskaya, E. V. Lebedinskaya, N. V. Medunitsyn, A. N. Mironov, N. A. Ozeretskovsky, A. A. Soldatov, V. A. Shevtsov
Published 2018-02-01